North America Laxative Market
市场规模(十亿美元)
CAGR : %
Forecast Period |
2024 –2031 |
Market Size (Base Year) |
USD 4.31 Billion |
Market Size (Forecast Year) |
USD 6.72 Billion |
CAGR |
|
Major Markets Players |
|
>北美泻药市场,按类型(渗透性泻药、刺激性泻药、容积性泻药、润滑剂和润肤剂泻药)、口味(有味和无味)、来源(天然、合成和其他)、适应症(慢性便秘、伴有便秘的肠易激综合征、阿片类药物引起的便秘、急性便秘和其他)、购买方式(处方和非处方)、剂型(片剂、胶囊、粉末、液体和凝胶、栓剂和其他)、给药途径(口服和直肠)、人群类型(儿童和成人)、销售渠道(医院、老年护理中心、家庭医疗保健、药店、杂货店/保健和美容店和其他)、分销渠道(直销、批发商和其他)划分 - 行业趋势和预测到 2031 年。
北美泻药市场分析和规模
泻药用于治疗便秘型肠易激综合征 (IBS-C) 的症状,这是一种以便秘为特征的肠易激综合征。泻药市场在 IBS-C 中具有重要应用,因为它有助于缓解排便困难和排便不频繁等症状。IBS-C 的患病率不断上升,尤其是在成年人中,推动了对这种适应症的泻药的需求。泻药用于治疗 IBS-C 症状,包括便秘、腹胀和腹痛。IBS-C 泻药市场的发展源于人们对胃肠道疾病的认识不断提高以及对有效治疗这些症状的需求。
2023 年北美泻药市场规模价值 43.1 亿美元,预计到 2031 年将达到 67.2 亿美元,2024 年至 2031 年预测期内的复合年增长率为 5.70%。
除了对市场价值、增长率、细分、地理覆盖范围和主要参与者等市场情景的洞察之外,Data Bridge Market Research 策划的市场报告还包括深度专家分析、患者流行病学、管道分析、定价分析和监管框架。
报告范围和市场细分
报告指标 |
细节 |
预测期 |
2024-2031 |
基准年 |
2023 |
历史岁月 |
2022 (可定制为 2016-2021) |
定量单位 |
收入(单位:十亿美元)、销量(单位:台)、定价(美元) |
涵盖的领域 |
类型(渗透性泻药、刺激性泻药、容积性泻药、润滑剂和润肤剂)、香料(有味和无味)、来源(天然、合成和其他)、适应症(慢性便秘、便秘性肠易激综合征、阿片类药物引起的便秘、急性便秘和其他)、购买方式(处方和非处方)、剂型(片剂、胶囊、粉末、液体和凝胶、栓剂和其他)、给药途径(口服和直肠)、人群类型(儿童和成人)、销售渠道(医院、老年护理中心、家庭医疗保健、药店、杂货店/保健和美容店和其他)、分销渠道(直销、批发商和其他) |
覆盖国家 |
美国、加拿大和墨西哥 |
涵盖的市场参与者 |
Boehringer Ingelheim International GmbH(德国)、GlaxoSmithKline plc(英国)、Bayer AG(德国)、Fresenius Kabi Austria GmbH(奥地利)、Prestige Consumer Healthcare Inc.(美国)、宝洁(美国)、Sun Pharmaceutical Industries Ltd(印度)、Sanofi Aventis LLC US(美国)、RECORDATI(意大利)、Mallinckrodt(美国)、Hikma Pharmaceuticals PLC(约旦)、雅培(美国)、Avrio Health LP(美国)、Dr Reddy's Laboratories Ltd(印度)、LNK INTERNATIONAL INC.(美国)、Cipla Inc.(印度)、Aspen Pharmacare Australia Pty Ltd(澳大利亚)、Salix PHARMACEUTICAL(美国)、Torrent Pharmaceuticals Ltd(印度) |
市场机会 |
|
市场定义
泻药是一种有助于解决便秘或在下肠道手术或手术前排空肠道粪便的药物。泻药的作用是软化或松散粪便、增加排便或促进肠道收缩以使粪便通过肠道。泻药有多种形式,包括口服药片、胶囊和栓剂,可用于治疗急性和慢性便秘。
泻药市场动态
驱动程序
- 胃肠道疾病患病率不断上升
许多人都过着久坐不动的生活方式,并且食用低纤维的加工食品,便秘率上升,导致对有效控制这些症状的泻药的需求增加。胃肠道问题负担的增加凸显了对方便有效的治疗方案的必要性,从而推动了泻药市场的增长。饮食不良、纤维摄入量低、水分不足和久坐不动的习惯等因素都会导致便秘,从而增加了对治疗相关症状的泻药的需求。
- 老年人口不断增长
Elderly individuals are more susceptible to constipation and other gastrointestinal issues due to age-related changes in bowel function. As the geriatric population expands, particularly in developed countries, the demand for laxatives to manage these age-related digestive problems has increased significantly. The need for effective bowel health management strategies to address the unique needs of aging populations has become a key factor propelling the growth of the laxative market. This demographic shift underscores the importance of accessible and reliable laxative products to maintain digestive wellness among the elderly.
Opportunities
- Increasing Healthcare Expenditure
As healthcare expenditure rises, particularly in emerging economies, it enhances access to healthcare services and medications like laxatives. This increased accessibility leads to greater affordability and availability of laxative products, driving market growth. The rising healthcare expenditure also reflects a growing recognition of the importance of digestive health, leading to increased demand for laxatives to manage gastrointestinal issues.
- Changing Dietary Habits
Sedentary lifestyles and poor dietary choices, such as low fiber intake, inadequate hydration, and increased consumption of processed and low-nutrient foods, contribute to the prevalence of constipation. These dietary factors can further increase the risk of constipation by affecting stool consistency, bowel transit time, and overall gut health. As a result, the increasing prevalence of constipation due to changing dietary habits drives the demand for laxatives and related products in the market.
Restraints/Challenges
- High Competition with Natural Remedies
The stiff competition from the growing popularity of natural remedies and alternative therapies for digestive health is increasing rapidly. Consumers are increasingly drawn to gentler, non-pharmacological solutions, leading to a shift in demand away from traditional laxatives. This trend reflects a broader preference for holistic approaches to wellness, challenging the market's reliance on conventional pharmaceutical products. As a result, the laxative market is impacted negatively by the growing interest in alternative solutions with fewer side effects.
- High Cost of Drug Development
Pharmaceutical companies spend tens to hundreds of millions of dollars on drug development, which can be a substantial financial burden. This cost includes out-of-pocket expenses and capitalized costs over a long period, typically 10 years or more. The average cost per drug developed and approved by a single-drug company is around $350 million, while for companies that approve multiple drugs, the cost can be as high as $5.5 billion. These high costs can deter companies from developing new laxatives, limiting the market's growth potential.
This market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Recent Development
- In January 2020, Fresenius Kabi Austria GmbH launched a new website providing detailed information on the use of laxatives, including lactulose. This initiative aimed to increase awareness about lactulose among consumers, boost purchase power, enhance the product portfolio, and ultimately drive net sales. The website focused on the benefits and proper use of lactulose, a synthetic laxative used to treat constipation. This move was expected to positively impact the company's sales and customer engagement
Laxative Market Scope
The market is segmented on the basis of type, flavours, source, indication, mode of purchase, dosage form, route of administration, population type, sales channel and distribution channel. The growth among segments helps you analyze niche pockets of growth and strategies to approach the market and determine your core application areas and the difference in your target markets.
Type
- Osmotic laxatives
- Osmotic laxatives with Electrolytes (Polyethylene Glycol)
- Golytely
- Colyte
- Others
- Osmotic Laxatives without Electrolytes
- Magnesium Hydroxide Solution
- Epsom Salts
- Lactulose
- Others
- Osmotic laxatives with Electrolytes (Polyethylene Glycol)
- Stimulant laxatives
- Bisacodyl
- Castor Oil
- Senna
- Phenolphthalein
- Others
- Bulk laxatives
- Psyllium
- Methyl Cellulose
- Polycarbophil
- Others
- Lubricant and Emollient laxatives
- Mineral Oil
- Glycerin Suppositories
- Others
Flavors
- With Flavor
- Fruit
- Herbal
- Others
- Without Flavor
Source
- Natural
- Psyllium
- Rhubarb
- Senna
- Slippery Elm
- Synthetic
- Phenolphthalein
- Bisacodyl
- Picosulfate
- Oxyphenisatin
- Others
Indication
- Chronic Constipation
- irritable bowel Syndrome with Constipation
- Opioid-Induced constipation
- Acute constipation
- Others
Mode of Purchase
- Prescription
- Over-the-Counter
Dosage Form
- Tablets
- Capsules
- Powder
- Liquid and Gels
- Suppositories
- Others
Route of Administration
- Oral
- Rectal
Population Type
- Children
- Adults
Sales Channel
- Hospitals
- Elderly Care Centers
- Home Healthcare
- Pharmacy Stores
- Grocery/Health and Beauty Stores
- Others
Distribution channel
- Direct Sales
- Wholesalers
- Others
North America Laxative Market Regional Analysis/Insights
The market is analyzed and market size insights and trends are provided by country, type, flavours, source, indication, mode of purchase, dosage form, route of administration, population type, sales channel and distribution channel as referenced above.
The market comprises the countries U.S., Canada and Mexico.
美国在市场份额和收入方面均占据市场主导地位,预计未来几年仍将保持主导地位。这一增长是由各行各业对手套的需求不断增长以及市场快速扩张推动的。
报告的国家部分还提供了影响单个市场因素和国内市场监管变化,这些因素和变化会影响市场的当前和未来趋势。下游和上游价值链分析、技术趋势和波特五力分析、案例研究等数据点是用于预测单个国家市场情景的一些指标。此外,在提供国家数据的预测分析时,还考虑了全球品牌的存在和可用性以及它们因来自本地和国内品牌的大量或稀缺竞争而面临的挑战、国内关税和贸易路线的影响。
医疗保健基础设施增长安装基础和新技术渗透
该市场还为您提供每个国家/地区资本设备医疗支出增长、市场上不同类型产品的安装基数、使用生命线曲线的技术影响以及医疗监管情景的变化及其对市场的影响的详细市场分析。数据适用于 2016-2021 年的历史时期。
竞争格局和泻药市场分析
市场竞争格局按竞争对手提供详细信息。详细信息包括公司概况、公司财务状况、产生的收入、市场潜力、研发投资、新市场计划、全球影响力、生产基地和设施、生产能力、公司优势和劣势、产品发布、产品宽度和广度、应用主导地位。以上提供的数据点仅与公司对全球养老院和长期护理设施市场的关注有关。
市场上的一些主要参与者包括:
- 勃林格殷格翰国际有限公司 (德国)
- 葛兰素史克公司 (英国)
- 拜耳公司(德国)
- Fresenius Kabi Austria GmbH(奥地利)
- Prestige Consumer Healthcare Inc.(美国)
- 宝洁(美国)
- 太阳制药工业有限公司 (印度)
- Sanofi Aventis LLC(美国)
- RECORDATI(意大利)
- Mallinckrodt(美国)
- Hikma Pharmaceuticals PLC(约旦)
- 雅培(美国)
- Avrio Health LP(美国)
- Dr Reddy's Laboratories Ltd(印度)
- LNK INTERNATIONAL INC.(美国)
- Cipla Inc.(印度)
- Aspen Pharmacare Australia Pty Ltd(澳大利亚)
- Salix PHARMACEUTICAL(美国)
- Torrent Pharmaceuticals Ltd (印度)
SKU-
Get online access to the report on the World's First Market Intelligence Cloud
- Interactive Data Analysis Dashboard
- Company Analysis Dashboard for high growth potential opportunities
- Research Analyst Access for customization & queries
- Competitor Analysis with Interactive dashboard
- Latest News, Updates & Trend analysis
- Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
研究方法
Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.
The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.
可定制
Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.